Clinical trial
Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery
NCT00770705 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery
- Lead sponsor
- Vanderbilt University
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- October 31, 2008
- Completion date
- August 31, 2010
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease